Pinsent Masons advises 4D Pharma PLC on innovative move to NASDAQ

28 Oct 2020 | 10:31 am | 1 min. read

Multinational law firm Pinsent Masons has advised AIM listed biotech company 4D Pharma plc (4D) on its acquisition of Longevity Acquisition Corporation, a special-purpose acquisition company (SPAC) listed on NASDAQ. Upon completion of the transaction 4D will apply for its American Depositary Shares to be admitted to trading on NASDAQ.

4D, who are leading the development of live biotherapeutic products, are believed to be the first UK biotech to make the move to NASDAQ via the acquisition of a SPAC, breaking new ground for UK listed biotechs. The Company will also maintain its current listing on AIM.

With 4D acquiring the SPAC in order to inherit its listing on NASDAQ, they are able to by-pass the usual nine month lead-in time foreign issuers have to contend with when seeking a direct listing on NASDAQ.

The Pinsent Masons team was led by Charles Waddell and Sunjay Malhotra with assistance from Julian Stanier, Amy Moore and Nathalie Goetsches; US securities advice was provided by Roberta Markovina and Beatrice Kelly; Eloise Walker, Jamie Robson and Daniel Place assisted on UK tax matters; and Fleur Benns and James Sullivan-Tailyour provided assistance with regards to 4D’s share option plans.

Commenting on the transaction, lead partner at Pinsent Masons Charles Waddell said:

"We have enjoyed working with 4D for a number of years, they are at the cutting edge of live biotherapeutic products and this transaction is an important step in their future development and access to key to international markets.

Given the number of European biotechs that covet a move to NASDAQ, and notwithstanding the complex financing structures of SPACs, this deal highlights that there is an alternative route to the US markets. It is therefore unlikely to be the last biotech we see looking at SPACs to access the deep pool of sophisticated investors in the US."

Latest press releases

Show me all press releases

Pinsent Masons advises on €1 billion variable annuity policies transfer

Multinational law firm Pinsent Masons Irish corporate insurance team has advised Athora Ireland plc (Athora) on its transfer of a book of variable annuity policies to Monument Life Insurance DAC, with assets under management valued at nearly €1 billion for circa 13,000 customers.

Grant Thornton and Pinsent Masons collaborate to support effective data sharing across financial services

Leading business and financial adviser Grant Thornton UK LLP and multinational law firm Pinsent Masons have joined forces to support firms with how they can share data safely, efficiently and effectively across financial services in a push to enable open finance.

Pinsent Masons partners with Tech Nation’s Rising Stars competition

Multinational law firm Pinsent Masons has partnered with Tech Nations’ Rising Stars competition to support innovative early-stage scaleups across the UK.

People who viewed this press release also viewed

Show me all press releases

Grant Thornton and Pinsent Masons collaborate to support effective data sharing across financial services

Leading business and financial adviser Grant Thornton UK LLP and multinational law firm Pinsent Masons have joined forces to support firms with how they can share data safely, efficiently and effectively across financial services in a push to enable open finance.

Pinsent Masons partners with Tech Nation’s Rising Stars competition

Multinational law firm Pinsent Masons has partnered with Tech Nations’ Rising Stars competition to support innovative early-stage scaleups across the UK.

Pinsent Masons makes dual hire in Amsterdam

Multinational law firm Pinsent Masons has hired two legal directors in Amsterdam, appointing Joel Erwteman and Stephanie Dekker as it continues to grow its technology, science and industry (TSI) capabilities in The Netherlands.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts